Article -> Article Details
Title | Dyslexia Treatment Market is Projected to Grow at a CAGR of 6.5% from 2018 to 2025 |
---|---|
Category | Fitness Health --> Addictions |
Meta Keywords | Dyslexia Treatment Market |
Owner | vinit |
Description | |
Market Highlights According to MRFR analysis, the global dyslexia
treatment market is expected to register a CAGR of 6.5% during the
forecast period of 2019 to 2025 and is expected to reach USD 26,884.5 Million
by 2025. Dyslexia is a neurological disorder leading to difficulty
reading, writing, and remembering difficult words. Though there's no cure for
dyslexia, the central nervous stimulant, anti-myoclonic, and attention-deficit
hyperactivity disorder (ADHD) drugs are prescribed to treat this disorder.
There are different apps, online programs, and visual & audio tools, and
instruments and devices used to improve the memory of patient having dyslexia. The growth of the global dyslexia treatment market is driven
by various factors such as increased spending in public health care on mental
health drives the market growth. However, the low awareness about diagnosis and
treatment of dyslexia, and the inefficient mental health infrastructure is
projected to hamper the growth of the global dyslexia treatment market. Regional Analysis The market has been divided, by region, into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa. The Americas is
expected to be the largest market owing to the rising per capita healthcare
expenditure. The dyslexia treatment market in the Americas has further been
branched into North America and Latin America, with the North American market
divided into the US and Canada. The European dyslexia treatment market has been
categorized as Western Europe and Eastern Europe. The Western European market
has further been classified as Germany, France, the UK, Italy, Spain, and the
rest of Western Europe. The dyslexia treatment market in Asia-Pacific has been
segmented into Japan, China, India, South Korea, Australia, and the rest of
Asia-Pacific. Due to the increasing patient population in the market in
Asia-Pacific is expected to be the fastest-growing. The dyslexia treatment
market in the Middle East & Africa has been divided into the Middle East
and Africa. Segmentation The global dyslexia treatment market has been segmented
based on type of dyslexia, treatment, route of administration, and end user. The market, based on type of dyslexia, has been divided into
phonological dyslexia and surface dyslexia. The phonological dyslexia segment
is likely to be the largest and fastest-growing segment. The global dyslexia treatment market has been segmented, on
the basis of treatment, into drug class, tools, and educational techniques. The
drug class segment is expected to be the largest segment owing to the increased
funding to develop drugs to treat neurological disorders. On the basis of end users of the market have been
segmented into psychiatric institutions, rehabilitation centers, home care, and
others. The mental institutions segment is expected to hold the largest share
of the market due to the increasing number of treatment centers for dyslexia. Key Players Some of the key players in the global dyslexia
treatment market are Jubilant Cadista (US), Pfizer Inc (US), Micro
Labs (India), Gangwal Chemicals Pvt. Ltd (India), Srikem Labs (India), Novartis
AG (UK), Purdue Pharma (US), RPG Life Sciences Ltd. Cian Healthcare Pvt. Ltd
(India), GlaxoSmithKline (UK), Teva Pharmaceutical Industries Ltd (Israel), Eli
Lilly & Company (US), and Wallace Pharmaceuticals Ltd (US). |